These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

82 related articles for article (PubMed ID: 8743526)

  • 21. [Comparison of clinical and ambulatory measurements of blood pressure with benazepril alone or combined with hydrochlorothiazide in hypertension].
    Le Feuvre C; Francillon A; Renucci JF; Cocco-Guyomarch L; Muller M; Peuplier P; Poggi L
    Therapie; 1996; 51(1):27-34. PubMed ID: 8762217
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Sibutramine is safe and effective for weight loss in obese patients whose hypertension is well controlled with angiotensin-converting enzyme inhibitors.
    McMahon FG; Weinstein SP; Rowe E; Ernst KR; Johnson F; Fujioka K;
    J Hum Hypertens; 2002 Jan; 16(1):5-11. PubMed ID: 11840224
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Metabolic effects of spirapril and atenolol: results from a randomized, long-term study.
    Hakamäki T; Lehtonen A
    Int J Clin Pharmacol Ther; 1997 Jun; 35(6):227-30. PubMed ID: 9208336
    [TBL] [Abstract][Full Text] [Related]  

  • 24. A randomized, double-blind, placebo-controlled, parallel-group study to assess the efficacy and safety of dual ACE/NEP inhibitor GW660511X in mild-to-moderate hypertensive patients.
    Johnson AG; Pearce GL; Danoff TM
    J Hum Hypertens; 2006 Jul; 20(7):496-503. PubMed ID: 16543907
    [TBL] [Abstract][Full Text] [Related]  

  • 25. A 26-week, prospective, open-label, uncontrolled, multicenter study to evaluate the effect of an escalating-dose regimen of trandolapril on change in blood pressure in treatment-naive and concurrently treated adult hypertensive subjects (TRAIL).
    Tytus RH; Burgess ED; Assouline L; Vanjaka A
    Clin Ther; 2007 Feb; 29(2):305-15. PubMed ID: 17472822
    [TBL] [Abstract][Full Text] [Related]  

  • 26. [Experience with benazepril, a long-acting ACE inhibitor, in the management of diabetic hypertension].
    Winkler G; Hajós P; Pál B; Tóth J
    Orv Hetil; 1997 Jul; 138(27):1737-42. PubMed ID: 9273485
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Effect of lacidipine, a dihydropyridine calcium antagonist on renal function of hypertensive patients with renal insufficiency.
    Bailey RR; Shand BI; Smith AH; Robson RA; Lynn KL
    Clin Nephrol; 1997 Oct; 48(4):224-9. PubMed ID: 9352156
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Combined inhibition of neutral endopeptidase and angiotensin-converting enzyme by sampatrilat in essential hypertension.
    Wallis EJ; Ramsay LE; Hettiarachchi J
    Clin Pharmacol Ther; 1998 Oct; 64(4):439-49. PubMed ID: 9797801
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Efficacy and safety of a therapeutic interchange from high-dose calcium channel blockers to a fixed-dose combination of amlodipine/benazepril in patients with moderate-to-severe hypertension.
    Hilleman DE; Reyes AP; Wurdeman RL; Faulkner M
    J Hum Hypertens; 2001 Aug; 15(8):559-65. PubMed ID: 11494095
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Renal and cardiac effects of antihypertensive treatment with ramipril vs metoprolol in autosomal dominant polycystic kidney disease.
    Zeltner R; Poliak R; Stiasny B; Schmieder RE; Schulze BD
    Nephrol Dial Transplant; 2008 Feb; 23(2):573-9. PubMed ID: 17984104
    [TBL] [Abstract][Full Text] [Related]  

  • 31. [Efficacy of benazepril monotherapy in moderate essential hypertension studied by automatic ambulatory blood pressure monitoring].
    Páll D; Juhász A; Karányi Z
    Orv Hetil; 1996 Sep; 137(36):1973-8. PubMed ID: 8927351
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Effect of combination of valsartan with benazepril on blood pressure and left ventricular hypertrophy in SHR.
    Ke YS; Cao H; Yang T
    Acta Pharmacol Sin; 2000 Nov; 21(11):1043-7. PubMed ID: 11501062
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Benazepril approved for treatment of hypertension.
    Clin Pharm; 1991 Oct; 10(10):739. PubMed ID: 1742957
    [No Abstract]   [Full Text] [Related]  

  • 34. Efficacy and safety of benazepril for advanced chronic renal insufficiency.
    Hou FF; Zhang X; Zhang GH; Xie D; Chen PY; Zhang WR; Jiang JP; Liang M; Wang GB; Liu ZR; Geng RW
    N Engl J Med; 2006 Jan; 354(2):131-40. PubMed ID: 16407508
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Systemic and renal effects of a new angiotensin converting enzyme inhibitor, benazepril, in essential hypertension.
    Valvo E; Casagrande P; Bedogna V; Antiga L; Alberti D; Zamboni M; Perobelli L; Dal Santo F; Maschio G
    J Hypertens; 1990 Nov; 8(11):991-5. PubMed ID: 1963190
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Angiotensin-converting enzyme inhibitors and kidney protection: the AIPRI trial. The ACE Inhibition in Progressive Renal Insufficiency (AIPRI) Study Group.
    Maschio G; Alberti D; Locatelli F; Mann JF; Motolese M; Ponticelli C; Ritz E; Janin G; Zucchelli P
    J Cardiovasc Pharmacol; 1999; 33 Suppl 1():S16-20; discussion S41-3. PubMed ID: 10028949
    [TBL] [Abstract][Full Text] [Related]  

  • 37. The use of benazepril in hypertensive patients age 55 and over.
    Smith WM; Gomez HJ
    Clin Cardiol; 1991 Aug; 14(8 Suppl 4):IV79-82; discussion IV83-90. PubMed ID: 1893647
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Blunting of atrial natriuretic factor response to volume expansion by benazepril in hypertensive patients.
    Dessì-Fulgheri P; Motolese M; Di Noto G; Delfino D; Giacchetti G; Boria C; Rappelli A
    J Hypertens Suppl; 1989 Dec; 7(6):S300-1. PubMed ID: 2561144
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Safety profile of benazepril in essential hypertension.
    MacNab M; Mallows S
    Clin Cardiol; 1991 Aug; 14(8 Suppl 4):IV33-7; discussion IV51-5. PubMed ID: 1893640
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Dose-response studies with benazepril in mild to moderate hypertension.
    Gomez HJ
    Clin Cardiol; 1991 Aug; 14(8 Suppl 4):IV22-7; discussion IV51-5. PubMed ID: 1893638
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 5.